INTEGRATED BIOPHARMA INC
For the period ended Oct 28, 2024. Filed Oct 28, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Oct 28, 2024 · Filed Oct 28, 2024
Use the contents to explore the available documents and sections.
INBPStored price and day change unavailable
Contents
ADDITIONAL INFORMATION
ADDITIONAL COPIES OF THE COMPANY’S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED JUNE 30, 2024, MAY BE OBTAINED WITHOUT CHARGE BY ANY STOCKHOLDER TO WHOM THIS PROXY STATEMENT IS SENT, UPON WRITTEN REQUEST TO THE SECRETARY, INTEGRATED BIOPHARMA, INC., 225 LONG AVENUE, HILLSIDE, NEW JERSEY 07205.
| By order of the Board of Directors | |
| /s/ Christina Kay | |
| Christina Kay | |
| / | /s/ Riva Sheppard |
|---|---|
| Riva Sheppard | |
| Co-Chief Executive Officers | |
| October 28, 2024 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.